Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PCDHB4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
METTL21B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIAS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FMNL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MOCS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRNP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
C9orf40 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYEF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZMYM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIS18A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNTNAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TXNL4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRPS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NMU - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPDYA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRMT13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SOGA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBPJL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on